Clinical Trials Browser

camrelizumab × Gastrointestinal × 30 days × Clear all

NCT07320586 2026-03-13

Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms